Immuneering Corp (IMRX)
1.48
+0.01
(+0.68%)
USD |
NASDAQ |
Apr 29, 16:00
1.50
+0.02
(+1.35%)
Pre-Market: 20:00
Immuneering Price: 1.48 for April 29, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 29, 2024 | 1.49 | 1.53 | 1.38 | 1.48 | 554526.0 |
Apr 26, 2024 | 1.43 | 1.51 | 1.43 | 1.47 | 295784.0 |
Apr 25, 2024 | 1.53 | 1.543 | 1.40 | 1.43 | 382352.0 |
Apr 24, 2024 | 1.61 | 1.65 | 1.47 | 1.50 | 471313.0 |
Apr 23, 2024 | 1.71 | 1.73 | 1.60 | 1.63 | 330889.0 |
Apr 22, 2024 | 1.77 | 1.79 | 1.69 | 1.72 | 331241.0 |
Apr 19, 2024 | 1.79 | 1.82 | 1.56 | 1.80 | 515620.0 |
Apr 18, 2024 | 1.89 | 1.89 | 1.76 | 1.77 | 178106.0 |
Apr 17, 2024 | 1.87 | 1.97 | 1.82 | 1.86 | 295376.0 |
Apr 16, 2024 | 1.89 | 1.96 | 1.75 | 1.84 | 689968.0 |
Apr 15, 2024 | 2.07 | 2.08 | 1.89 | 1.915 | 857129.0 |
Apr 12, 2024 | 2.08 | 2.14 | 2.03 | 2.10 | 257603.0 |
Apr 11, 2024 | 2.05 | 2.11 | 1.93 | 2.08 | 720030.0 |
Apr 10, 2024 | 2.08 | 2.165 | 1.975 | 2.01 | 1.290M |
Apr 09, 2024 | 2.12 | 2.22 | 2.05 | 2.19 | 396602.0 |
Apr 08, 2024 | 2.20 | 2.31 | 2.00 | 2.12 | 749737.0 |
Apr 05, 2024 | 2.34 | 2.36 | 2.17 | 2.19 | 531979.0 |
Apr 04, 2024 | 2.45 | 2.52 | 2.276 | 2.35 | 466631.0 |
Apr 03, 2024 | 2.49 | 2.60 | 2.36 | 2.40 | 449747.0 |
Apr 02, 2024 | 2.72 | 2.74 | 2.46 | 2.50 | 558974.0 |
Apr 01, 2024 | 2.83 | 3.15 | 2.75 | 2.75 | 1.458M |
Mar 28, 2024 | 2.42 | 2.97 | 2.40 | 2.89 | 962839.0 |
Mar 27, 2024 | 2.42 | 2.48 | 2.26 | 2.43 | 705205.0 |
Mar 26, 2024 | 2.52 | 2.61 | 2.35 | 2.39 | 622621.0 |
Mar 25, 2024 | 2.67 | 2.67 | 2.50 | 2.53 | 480222.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.43
Minimum
Apr 25 2024
32.84
Maximum
Sep 27 2021
10.22
Average
7.48
Median
Nov 14 2022
Price Benchmarks
Geron Corp | 4.14 |
SELLAS Life Sciences Group Inc | 1.21 |
Elicio Therapeutics Inc | 9.10 |
Vistagen Therapeutics Inc | 4.77 |
ADMA Biologics Inc | 6.58 |
Price Related Metrics
PS Ratio | 132.65 |
PEG Ratio | -0.0554 |
Price to Book Value | 0.4845 |
Earnings Yield | -127.7% |
Market Cap | 43.89M |
PEGY Ratio | -0.0554 |